Chinese Robotics Stocks Rise Ahead of Unitree Report

Shares of Chinese robotics companies extended their rally on expectations of shorter timelines for mass adoption. A report from industry leader Yushu Technology Co., also known as Unitree Robotics, is expected to give the sector a new boost: results are anticipated on Wednesday.
Yushu rose 15% intraday and has gained about 60% since the beginning of October. Shandong Daye, which produces tendon ropes for robotic dexterous hands, rose 3%, bringing its growth since the start of the month to over 70%. OPT Machine Vision Tech and Shenzhen Zhaowei Machinery & Electronic also saw increases.
The sector is moving against the overall decline in Chinese AI stocks, driven by concerns over inflated valuations and intense domestic competition. A key catalyst was the words of Unitree CEO Xinxin Wang: a breakthrough in humanoid robots could come in just two years, rather than ten as he previously estimated. Following this, JPMorgan twice upgraded Unitree's rating to overweight.
"The rally partly reflects investor speculation ahead of the earnings report," said Shen Meng, director of Beijing investment bank Chanson & Co., about Unitree. "I am cautious in assessing the short-term prospects for commercialization, but revenue could be strong due to demonstrations and entertainment."
What to expect from the report
According to Bloomberg Intelligence, Unitree's third-quarter revenue is likely to grow: trade data points to stronger overseas demand. China's export of intelligent bionic robots for July–August amounted to about 454 million yuan ($68 million) – 64% of the total volume for the first half of the year.
China has taken an early lead in robotics: Chinese companies accounted for 97% of global humanoid shipments in the first half of the year. Wang stated last week that Unitree will expand production capacity to meet demand, which could reach tens of millions of machines. Optimism is also fueled by policy: authorities have stated that China will accelerate the use of AI, robotics, and other new technologies in the trade chain to increase supply for the domestic market.
Risks
The humanoid robot industry remains in the early stages of commercialization. After the stock surge, Unitree warned of revenue growth uncertainties, noting risks related to the technology itself, downstream demand, and supply chain capabilities.
"The situation changed after the World Conference on Physical AI 2026 in Hangzhou," wrote JPMorgan analysts, including Karen Li, in a Sunday note. "Rapid progress in advanced models shifts the industry's bottleneck from the 'brain' to the 'last mile' of interaction with the real world, and the installed base and platform positioning become more valuable."
This material is prepared solely for informational purposes and does not constitute financial advice or a recommendation.





